SCHEMBL108588

SCHEMBL108588

COC(=O)c1ccc(S(=O)(=O)NCc2ccccc2)c(C)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.55
CYP1A2 P05177 1/20 0.53
CYP2C19 P33261 1/20 0.53
FABP4 P15090 2/20 0.53
ALDH1A1 P00352 5/20 0.52
MAPT P10636 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
KDM4E B2RXH2 2/20 0.52
TP53 P04637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.51
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
GAA P10253 2/20 0.49
HPGD P15428 2/20 0.48
LMNA P02545 1/20 0.48
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL119144 0.86 FABP4 (0.61) POLBCYP1A2CYP2C19FABP4ALDH1A1
SCHEMBL119541 0.86 SMN1; SMN2 (0.54) POLBCYP1A2CYP2C19FABP4ALDH1A1
SCHEMBL119461 0.80 POLB (0.72) POLBCYP1A2CYP2C19ALDH1A1MAPT
SCHEMBL119854 0.78 MAPT (0.64) CYP1A2CYP2C19ALDH1A1MAPTSMN1; SMN2
SCHEMBL904772 0.78 CHRNA7 (0.50) POLBALDH1A1MAPTMEN1KMT2A
SCHEMBL119014 0.77 POLB (0.61) POLBCYP1A2CYP2C19ALDH1A1MAPT
SCHEMBL120177 0.77 LMNA (0.66) POLBCYP1A2CYP2C19MAPTKMT2A
SCHEMBL3850206 0.77 POLB (0.72) POLBCYP1A2ALDH1A1MAPTSMN1; SMN2
SCHEMBL975460 0.77 CA9 (0.73) CYP1A2CYP2C19FABP4ALDH1A1MEN1
SCHEMBL904733 0.76 PDE1C (0.43) POLBALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2012-04-19 US disclosed
EP-2424517-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RaQualia Pharma Inc (JP) 2012-03-07 EP disclosed
WO-2010125831-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS RAQUALIA PHARMA INC. (JP) 2010-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094964-A1 SULFAMOYL BENZOIC ACID DERIVATIVES AS TRPM8 ANTAGONISTS TRPM8, TRPM5, TRPM6 POLB 4630/4885CYP1A2 2926/4885CYP2C19 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.